Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Guette

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cancers|April 16, 2020
S100A4 is a Biomarker of Tumorigenesis, EMT, Invasion, and Colonization of Host Organs in Experimental Malignant MesotheliomaJoëlle S Nader, Jordan Guillon, Coralie Petit, et al.
Molecular & Cellular Proteomics : MCP|October 12, 2011
A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor markerDamien Besson, Aude-Hélène Pavageau, Isabelle Valo, et al.
Nature Communications|October 26, 2017
BCL-X<sub>L</sub> directly modulates RAS signalling to favour cancer cell stemnessSophie de Carné Trécesson, Frédérique Souazé, Agnès Basseville, et al.
International Journal of Oncology|May 4, 2012
Identification of potential prognostic biomarkers for node-negative breast tumours by proteomic analysis: a multicentric 2004 national PHRC studyFrançoise Descotes, Pascal Jézéquel, Frédérique Spyratos, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cancers|April 16, 2020
S100A4 is a Biomarker of Tumorigenesis, EMT, Invasion, and Colonization of Host Organs in Experimental Malignant MesotheliomaJoëlle S Nader, Jordan Guillon, Coralie Petit, et al.
Molecular & Cellular Proteomics : MCP|October 12, 2011
A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor markerDamien Besson, Aude-Hélène Pavageau, Isabelle Valo, et al.
Nature Communications|October 26, 2017
BCL-X<sub>L</sub> directly modulates RAS signalling to favour cancer cell stemnessSophie de Carné Trécesson, Frédérique Souazé, Agnès Basseville, et al.
International Journal of Oncology|May 4, 2012
Identification of potential prognostic biomarkers for node-negative breast tumours by proteomic analysis: a multicentric 2004 national PHRC studyFrançoise Descotes, Pascal Jézéquel, Frédérique Spyratos, et al.
Pageof 6